A number of doctor-prescribed drugs, such as copyright and Semaglutide, fall under the GLP-1 group. Mainly, these drugs work by mimicking the body's own hormones that impact blood glucose and stimulate a reduction in weight . Although copyright is a commercial product for type 2 diabetes , Semaglutide comes in multiple applications, such as a appr

Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, copyright, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. Thi